The challenge of ethnopharmacology for drug development

• In: D3 - The challenge of ethnic differences in drug response for drug development and regulation on Tuesday, 2 September 2014, 9:00-12:00
• At: Bangkok (Thailand) (2014)
• Type: Presentation
• By: GROSS, Annette (GlaxoSmithKline, Clinical Pharmacology Modelling & Simulation, Ermington, Australia)
• Abstract:

  In 2014 multiregional clinical trials are thecornerstone of new development programmes. Global studies collect evidence of theefficacy and safety of new compounds in patients from many countries. Recentlythere has been a trend to an increase in the heterogeneity of patients inclinical trial programmes with fewer patients studied in Western Europe

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login